Skip to content
healthcare.dev

Naproxen Sodium Diphenhydramine HCL

NDC 79903-204, Naproxen Sodium Diphenhydramine HCL, tablet, from Walmart.

Product NDC
79903-204
Status
Listed
Labeler
Walmart
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA213663
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/79903-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIPHENHYDRAMINE HYDROCHLORIDE25 mg/1
  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
79903-204-207990302042020 TABLET in 1 BOTTLE (79903-204-20)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 79903-204 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/79903-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 79903-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.